TERM ID="NYU_TERM_1" STRING="HER2" FREQUENCY=3 START=47 END=51 LEMMA="HUMAN EPIDERMAL GROWTH FACTOR RECEPTOR 2" LEMMA_FREQUENCY=3
TERM ID="NYU_TERM_2" STRING="HER2" FREQUENCY=3 START=526 END=530 LEMMA="HUMAN EPIDERMAL GROWTH FACTOR RECEPTOR 2" LEMMA_FREQUENCY=3
TERM ID="NYU_TERM_3" STRING="HER2" FREQUENCY=3 START=812 END=816 LEMMA="HUMAN EPIDERMAL GROWTH FACTOR RECEPTOR 2" LEMMA_FREQUENCY=3
TERM ID="NYU_TERM_4" STRING="blood-brain barrier" FREQUENCY=1 START=911 END=930 LEMMA="BLOOD-BRAIN BARRIER" LEMMA_FREQUENCY=1
TERM ID="NYU_TERM_5" STRING="brain metastases" FREQUENCY=5 START=13 END=29 LEMMA="BRAIN METASTAS" LEMMA_FREQUENCY=5
TERM ID="NYU_TERM_6" STRING="brain metastases" FREQUENCY=5 START=358 END=374 LEMMA="BRAIN METASTAS" LEMMA_FREQUENCY=5
TERM ID="NYU_TERM_7" STRING="brain metastases" FREQUENCY=5 START=661 END=677 LEMMA="BRAIN METASTAS" LEMMA_FREQUENCY=5
TERM ID="NYU_TERM_8" STRING="brain metastases" FREQUENCY=5 START=791 END=807 LEMMA="BRAIN METASTAS" LEMMA_FREQUENCY=5
TERM ID="NYU_TERM_9" STRING="brain metastases" FREQUENCY=5 START=1043 END=1059 LEMMA="BRAIN METASTAS" LEMMA_FREQUENCY=5
TERM ID="NYU_TERM_10" STRING="breast cancer Brain metastases" FREQUENCY=1 START=53 END=83 LEMMA="BREAST CANCER BRAIN METASTAS" LEMMA_FREQUENCY=1
TERM ID="NYU_TERM_11" STRING="clinical aspects" FREQUENCY=1 START=196 END=212 LEMMA="CLINICAL ASPECT" LEMMA_FREQUENCY=1
TERM ID="NYU_TERM_12" STRING="complication" FREQUENCY=1 START=99 END=111 LEMMA="COMPLICATION" LEMMA_FREQUENCY=1
TERM ID="NYU_TERM_13" STRING="epidermal growth factor receptor" FREQUENCY=1 START=481 END=513 LEMMA="EPIDERMAL GROWTH FACTOR RECEPTOR" LEMMA_FREQUENCY=1
TERM ID="NYU_TERM_14" STRING="intracranial lesions" FREQUENCY=1 START=1209 END=1229 LEMMA="INTRACRANIAL LESION" LEMMA_FREQUENCY=1
TERM ID="NYU_TERM_15" STRING="maintaining treatment" FREQUENCY=1 START=1129 END=1150 LEMMA="MAINTAINING TREATMENT" LEMMA_FREQUENCY=1
TERM ID="NYU_TERM_16" STRING="significance" FREQUENCY=1 START=342 END=354 LEMMA="SIGNIFICANCE" LEMMA_FREQUENCY=1
TERM ID="NYU_TERM_17" STRING="significance of brain metastases" FREQUENCY=1 START=342 END=374 LEMMA="BRAIN METASTAS SIGNIFICANCE" LEMMA_FREQUENCY=1 HEAD_TERM="significance" HEAD_LEMMA="SIGNIFICANCE"
TERM ID="NYU_TERM_18" STRING="stereotactic radiotherapy" FREQUENCY=1 START=713 END=738 LEMMA="STEREOTACTIC RADIOTHERAPY" LEMMA_FREQUENCY=1
TERM ID="NYU_TERM_19" STRING="survival rates" FREQUENCY=1 START=568 END=582 LEMMA="SURVIVAL RATE" LEMMA_FREQUENCY=1
TERM ID="NYU_TERM_20" STRING="trastuzumab" FREQUENCY=3 START=833 END=844 LEMMA="TRASTUZUMAB" LEMMA_FREQUENCY=3
TERM ID="NYU_TERM_21" STRING="trastuzumab" FREQUENCY=3 START=990 END=1001 LEMMA="TRASTUZUMAB" LEMMA_FREQUENCY=3
TERM ID="NYU_TERM_22" STRING="trastuzumab" FREQUENCY=3 START=1156 END=1167 LEMMA="TRASTUZUMAB" LEMMA_FREQUENCY=3
TERM ID="NYU_TERM_23" STRING="treatment options" FREQUENCY=1 START=270 END=287 LEMMA="TREATMENT OPTION" LEMMA_FREQUENCY=1
